<VariationArchive VariationID="6081" VariationName="NM_003661.4(APOL1):c.1164_1169del (p.Asn388_Tyr389del)" VariationType="Deletion" Accession="VCV000006081" Version="21" RecordType="classified" NumberOfSubmissions="9" NumberOfSubmitters="8" DateLastUpdated="2024-07-23" DateCreated="2013-04-04" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="21120" VariationID="6081">
      <GeneList>
        <Gene Symbol="APOL1" FullName="apolipoprotein L1" GeneID="8542" HGNC_ID="HGNC:618" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>22q12.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="36253133" stop="36267525" display_start="36253133" display_stop="36267525" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="36649116" stop="36663576" display_start="36649116" display_stop="36663576" Strand="+" />
          </Location>
          <OMIM>603743</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_003661.4(APOL1):c.1164_1169del (p.Asn388_Tyr389del)</Name>
      <CanonicalSPDI>NC_000022.11:36265995:ATAATTATAA:ATAA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>22q12.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="36265996" stop="36266001" display_start="36265996" display_stop="36266001" variantLength="6" positionVCF="36265995" referenceAlleleVCF="AATAATT" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="36662042" stop="36662047" display_start="36662042" display_stop="36662047" variantLength="6" positionVCF="36662041" referenceAlleleVCF="AATAATT" alternateAlleleVCF="A" />
      </Location>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003661.3" sequenceAccession="NM_003661" sequenceVersion="3" change="c.1164_1169delTTATAA">
            <Expression>NM_003661.3:c.1164_1169delTTATAA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_145343.2" sequenceAccession="NM_145343" sequenceVersion="2" change="c.1212_1217delTTATAA">
            <Expression>NM_145343.2:c.1212_1217delTTATAA</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.10" sequenceAccession="NC_000022" sequenceVersion="10" change="g.36662046_36662051del" Assembly="GRCh37">
            <Expression>NC_000022.10:g.36662046_36662051del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.11" sequenceAccession="NC_000022" sequenceVersion="11" change="g.36266000_36266005del" Assembly="GRCh38">
            <Expression>NC_000022.11:g.36266000_36266005del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_023228.1" sequenceAccession="NG_023228" sequenceVersion="1" change="g.17930_17935del">
            <Expression>NG_023228.1:g.17930_17935del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001136540.2" sequenceAccession="NM_001136540" sequenceVersion="2" change="c.1164_1169del">
            <Expression>NM_001136540.2:c.1164_1169del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001130012.1" sequenceAccession="NP_001130012" sequenceVersion="1" change="p.Asn388_Tyr389del">
            <Expression>NP_001130012.1:p.Asn388_Tyr389del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001136541.2" sequenceAccession="NM_001136541" sequenceVersion="2" change="c.1110_1115del">
            <Expression>NM_001136541.2:c.1110_1115del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001130013.1" sequenceAccession="NP_001130013" sequenceVersion="1" change="p.Asn370_Tyr371del">
            <Expression>NP_001130013.1:p.Asn370_Tyr371del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001362927.2" sequenceAccession="NM_001362927" sequenceVersion="2" change="c.1110_1115del">
            <Expression>NM_001362927.2:c.1110_1115del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001349856.1" sequenceAccession="NP_001349856" sequenceVersion="1" change="p.Asn370_Tyr371del">
            <Expression>NP_001349856.1:p.Asn370_Tyr371del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003661.4" sequenceAccession="NM_003661" sequenceVersion="4" change="c.1164_1169del" MANESelect="true">
            <Expression>NM_003661.4:c.1164_1169del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003652.2" sequenceAccession="NP_003652" sequenceVersion="2" change="p.Asn388_Tyr389del">
            <Expression>NP_003652.2:p.Asn388_Tyr389del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_145343.3" sequenceAccession="NM_145343" sequenceVersion="3" change="c.1212_1217del">
            <Expression>NM_145343.3:c.1212_1217del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_663318.1" sequenceAccession="NP_663318" sequenceVersion="1" change="p.Asn404_Tyr405del">
            <Expression>NP_663318.1:p.Asn404_Tyr405del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_169" sequenceAccession="LRG_169">
            <Expression>LRG_169:g.17930_17935del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003661.4" sequenceAccession="NM_003661" sequenceVersion="4" change="c.1164_1169delTTATAA" MANESelect="true">
            <Expression>NM_003661.4:c.1164_1169delTTATAA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA117932" DB="ClinGen" />
        <XRef ID="GTR000558473" DB="Genetic Testing Registry (GTR)" />
        <XRef ID="GTR000593348" DB="Genetic Testing Registry (GTR)" />
        <XRef Type="Allelic variant" ID="603743.0002" DB="OMIM" />
        <XRef Type="rs" ID="71785313" DB="dbSNP" />
        <XRef Type="Interpreted" ID="1120175" DB="ClinVar" />
      </XRefList>
      <GlobalMinorAlleleFrequency Value="0.03514" Source="1000 Genomes Project" MinorAllele="ATAA" />
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003661.4(APOL1):c.1164_1169del (p.Asn388_Tyr389del) AND Focal segmental glomerulosclerosis 4, susceptibility to" Accession="RCV000006454" Version="9">
        <ClassifiedConditionList TraitSetID="1684">
          <ClassifiedCondition DB="MedGen" ID="C2675525">Focal segmental glomerulosclerosis 4, susceptibility to</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-03-24" SubmissionCount="3">Likely risk allele; risk factor</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003661.4(APOL1):c.1164_1169del (p.Asn388_Tyr389del) AND Focal segmental glomerulosclerosis" Accession="RCV001003838" Version="2">
        <ClassifiedConditionList TraitSetID="40672">
          <ClassifiedCondition DB="MedGen" ID="C0017668">Focal segmental glomerulosclerosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003661.4(APOL1):c.1164_1169del (p.Asn388_Tyr389del) AND Nephrotic range proteinuria" Accession="RCV001003839" Version="2">
        <ClassifiedConditionList TraitSetID="52441">
          <ClassifiedCondition DB="MedGen" ID="C0445118">Nephrotic range proteinuria</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003661.4(APOL1):c.1164_1169del (p.Asn388_Tyr389del) AND Hyalinosis, Segmental Glomerular" Accession="RCV001195105" Version="5">
        <ClassifiedConditionList TraitSetID="54057">
          <ClassifiedCondition DB="MedGen" ID="C0086432">Hyalinosis, Segmental Glomerular</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-03-04" SubmissionCount="1">risk factor</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003661.4(APOL1):c.1164_1169del (p.Asn388_Tyr389del) AND not provided" Accession="RCV001295848" Version="10">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
            <Description DateLastEvaluated="2024-01-25" SubmissionCount="2">Conflicting interpretations of pathogenicity</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003661.4(APOL1):c.1164_1169del (p.Asn388_Tyr389del) AND not specified" Accession="RCV004585990" Version="1">
        <ClassifiedConditionList TraitSetID="9590">
          <ClassifiedCondition DB="MedGen" ID="CN169374">not specified</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-04-29" SubmissionCount="1">Likely benign</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-04-29" NumberOfSubmissions="9" NumberOfSubmitters="8" DateCreated="2013-04-04" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity; risk factor</Description>
        <Explanation DataSource="ClinVar" Type="public">Likely risk allele(1); Uncertain significance(1); Benign(1); Likely benign(1)</Explanation>
        <Citation Type="Suggested Reading" Abbrev="Parsa et al., 2013">
          <ID Source="PubMed">24206458</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20635188</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20647424</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20668430</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21997394</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25788523</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25993319</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28218918</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28650456</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30332315</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30340464</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32581362</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32675303</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Likely risk allele(1); Uncertain significance(1); Benign(1); Likely benign(1)</Comment>
        <DescriptionHistory Dated="2022-03-16">
          <Description>Conflicting classifications of pathogenicity, risk factor</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2021-09-18">
          <Description>Uncertain significance, risk factor</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2021-03-07">
          <Description>risk factor</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="52441" Type="Finding" ContributesToAggregateClassification="false">
            <Trait ID="30473" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Nephrotic range proteinuria</ElementValue>
                <XRef ID="HP:0012593" DB="Human Phenotype Ontology" />
              </Name>
              <XRef ID="C0445118" DB="MedGen" />
              <XRef Type="primary" ID="HP:0012593" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="40672" Type="Finding" ContributesToAggregateClassification="false">
            <Trait ID="21418" Type="Finding">
              <Name>
                <ElementValue Type="Alternate">Glomerulosclerosis, focal</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Focal sclerosis with hyalinosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Focal segmental glomerulosclerosis</ElementValue>
                <XRef ID="CN037700" DB="ADAM" />
                <XRef ID="HP:0000097" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0100313" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">FSGS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6517" />
                <XRef ID="6517" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000553522" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552013" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529072" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000523187" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528276" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558473" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500214" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558125" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515530" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558132" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522221" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <XRef ID="C0017668" DB="MedGen" />
              <XRef ID="MONDO:0100313" DB="MONDO" />
              <XRef Type="primary" ID="HP:0000097" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004747" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9590" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16789" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not specified</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">AllHighlyPenetrant</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not specified' was created for use in ClinVar so that submitters can convey the concept that a variant is benign, likely benign, or of uncertain significance for an unspecified set of disorders.  This usage was introduced in 2014 to replace AllHighlyPenetrant.</Attribute>
              </AttributeSet>
              <XRef ID="CN169374" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1684" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2144" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Focal segmental glomerulosclerosis 4, susceptibility to</ElementValue>
                <XRef ID="Focal+segmental+glomerulosclerosis+4%2C+susceptibility+to/8438" DB="Genetic Alliance" />
                <XRef ID="MONDO:0012931" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">FSGS4</ElementValue>
                <XRef Type="MIM" ID="612551" DB="OMIM" />
              </Symbol>
              <Citation Type="Suggested Reading" Abbrev="Parsa et al., 2013">
                <ID Source="PubMed">24206458</ID>
              </Citation>
              <XRef ID="84271" DB="Orphanet" />
              <XRef ID="C2675525" DB="MedGen" />
              <XRef ID="MONDO:0012931" DB="MONDO" />
              <XRef Type="MIM" ID="612551" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="54057" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="53553" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hyalinosis, Segmental Glomerular</ElementValue>
                <XRef ID="76957408" DB="NCBI for submitter" />
              </Name>
              <XRef ID="C0086432" DB="MedGen" />
              <XRef ID="D005923" DB="MeSH" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="26637" SubmissionDate="2010-10-25" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="603743.0002_FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4, SUSCEPTIBILITY TO" title="APOL1, 6-BP DEL, N388/Y389 (rs71785313)_FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4, SUSCEPTIBILITY TO" />
        <ClinVarAccession Accession="SCV000026637" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2010-08-13">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>risk factor</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In an association analysis comparing 205 African Americans with biopsy-proven focal segmental glomerulosclerosis (FSGS4; 612551) and no family history of FSGS with 180 African American controls, Genovese et al. (2010) identified association with FSGS of a 6-bp deletion, rs71785313, which they termed allele G2, in the last exon of the APOL1 gene. This mutation resulted in the deletion of 6 basepairs and removal of amino acids asparagine-388 (N388) and tyrosine-389 (Y389). The G2 allele was detected in 3 Yoruban participants but not in any patients from Europe, Japan, or China, all from HapMap 1000 Genomes data. The 6-bp deletion occurs at the SRA binding site in the APOL1 C-terminal helix. Genovese et al. (2010) showed that human plasma samples and recombinant APOL1 protein carrying the G2 allele lysed both SRA-negative and SRA-positive T. b. rhodesiense parasites, but not T. b. gambiense.</Attribute>
              <Citation>
                <ID Source="PubMed">20647424</ID>
              </Citation>
              <XRef DB="OMIM" ID="612551" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APOL1" />
          </GeneList>
          <Name>APOL1, 6-BP DEL, N388/Y389 (rs71785313)</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">6-BP DEL, N388/Y389 (rs71785313)</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603743.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4, SUSCEPTIBILITY TO</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="355013" SubmissionDate="2020-06-03" DateLastUpdated="2020-07-03" DateCreated="2015-01-31">
        <ClinVarSubmissionID localKey="36972190|MeSH:D005923" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000197066" DateUpdated="2020-07-03" DateCreated="2015-01-31" Type="SCV" Version="4" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-03-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>risk factor</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24206458</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21997394</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25993319</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28218918</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28650456</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20668430</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20635188</ID>
          </Citation>
          <Comment>APOL1 c.1164_1169del (p.Asn388_Tyr389del), traditionally referred to as G1, has been associated with increased risk for multiple renal diseases in African Americans, particularly focal segmental glomerulosclerosis (FSGS), as well as an increased risk for end-stage kidney disease (ESKD). This variant is common in individuals of African ancestry (14%, Genome Aggregation Database (gnomAD); rs71785313) and is present in ClinVar (ID: 6081). Several small case-control studies have reported odds ratios between 3.92-25.1 for developing FSGS/HIVAN in homozygous individuals (OR=3.92 [95% CI 1.47-9.39] for FSGS/HIVAN Ito 2014, OR=14.4 [95% CI 1.7-116.3] for HIVAN, OR=25.1 [95% CI 8.8-83.3] for FSGS Kopp 2011, OR=5.69 [95% CI not given, P&lt;0.00001] Limou 2015). In vitro and in vivo studies provide some evidence that these alleles impact protein function (Beckerman 2017, Hayek 2017). In summary, this variant is an established risk factor for chronic kidney disease in homozygous state.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LMM Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">24033266</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="36" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="36" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APOL1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000022.10:g.36662046_36662051delTTATAA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Hyalinosis, Segmental Glomerular</ElementValue>
            </Name>
            <XRef DB="MeSH" ID="D005923" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7546315</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2924429" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2021-03-07">
        <ClinVarSubmissionID localKey="1903333|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001484798" DateUpdated="2024-02-20" DateCreated="2021-03-07" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20647424</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20635188</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21997394</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30340464</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25788523</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30332315</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32675303</ID>
          </Citation>
          <Comment>This variant, c.1164_1169del, results in the deletion of 2 amino acid(s) of the APOL1 protein (p.Asn388_Tyr389del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs143830837, gnomAD 14%), and has an allele count higher than expected for a pathogenic variant. This variant constitutes the ‚ÄúG2‚Äù allele of APOL1. This allele is associated with increased risk for several forms of kidney disease in individuals of African-American ancestry when present in homozygosity or in trans with the ‚ÄúG1‚Äù allele (which is composed of the c.1024A&gt;G (p.Ser342Gly) and c.1152T&gt;G (p.Ile384Met) variants in cis). Several large case-control studies have shown a 6- to 47-fold increased risk of focal segmental glomerulosclerosis, HIV-associated nephropathy, or non-diabetic end-stage kidney disease in individuals with homozygous G1, homozygous G2, or G1 in trans with G2 alleles (PMID: 20647424, 20635188, 21997394). Similar studies in African populations have generally recapitulated these findings, but these studies are based on a relatively small number of individuals (PMID: 30340464, 25788523). A recent PheWAS study also appears to support these findings, although the risk of end-stage kidney disease may be smaller than initially assumed (closer to 3- to 4-fold; PMID: 32247630). ClinVar contains an entry for this variant (Variation ID: 6081). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on APOL1 function (PMID: 30332315, 32675303). In summary, this variant has been shown to confer an increased risk for kidney disease, either in homozygosity or in trans with the G1 allele. However, its significance when present in heterozygosity is unclear. For these reasons, this change has been classified as a Variant of Uncertain Significance.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APOL1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000022.10:g.36662042_36662047del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9856528" SubmissionDate="2024-07-09" DateLastUpdated="2024-07-15" DateCreated="2024-07-15">
        <ClinVarSubmissionID localKey="NM_003661.4:c.1164_1169delTTATAA|MedGen:CN169374" />
        <ClinVarAccession Accession="SCV005077605" DateUpdated="2024-07-15" DateCreated="2024-07-15" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-04-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely benign</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APOL1" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003661.4:c.1164_1169delTTATAA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN169374" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>clinvar-submission.2024-04.revised.csv</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1807723" SubmissionDate="2017-01-20" DateLastUpdated="2019-06-23" DateCreated="2019-06-23">
        <ClinVarSubmissionID localKey="NM_145343.2:c.1212_1217delTTATAA" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000924397" DateUpdated="2019-06-23" DateCreated="2019-06-23" Type="SCV" Version="1" SubmitterName="Molecular Diagnostics Lab, Nemours Children's Health, Delaware" OrgID="28338" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-02-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>risk factor</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20647424</ID>
          </Citation>
          <Comment>G2</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">50</Age>
              <Age Type="maximum" age_unit="years">59</Age>
              <AffectedStatus>no</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <Comment>G2/wild type; identical twin sister with end-stage renal disease, this individual tested as part of a living donor workup</Comment>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <Comment>G2/wild type; sickle cell anemia</Comment>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>biparental</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">20</Age>
              <Age Type="maximum" age_unit="years">29</Age>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <Comment>G2/G2</Comment>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">20</Age>
              <Age Type="maximum" age_unit="years">29</Age>
              <AffectedStatus>no</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <Comment>G2/wild type; tested as a candidate donor for affected brother (individual in line 26)</Comment>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>biparental</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">30</Age>
              <Age Type="maximum" age_unit="years">39</Age>
              <AffectedStatus>no</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <Comment>G1/G2; mother and brother with end stage renal disease of unknown cause, tested as part of a living donor workup.</Comment>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APOL1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_145343.2:exon 7</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="dbSNP" ID="71785313" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145343.2:c.1212_1217delTTATAA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="612551" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB2332378</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2290366" SubmissionDate="2019-09-13" DateLastUpdated="2020-02-27" DateCreated="2020-02-27">
        <ClinVarSubmissionID localKey="c.1212_1217delTTATAA_HP:0012593" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001162290" DateUpdated="2020-02-27" DateCreated="2020-02-27" Type="SCV" Version="1" SubmitterName="NIHR Bioresource Rare Diseases, University of Cambridge" OrgID="505998" OrganizationCategory="consortium" OrgAbbreviation="NIHR BR RD" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">32581362</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">S014193</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APOL1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="22" alternateAllele="A" referenceAllele="AATAATT" start="36662041" stop="36662047" variantLength="7" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145343.2:c.1212_1217delTTATAA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="HP" ID="HP:0012593" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">32581362</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32581362</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>NIHR_Bioresource_Rare_Diseases_13k</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2290365" SubmissionDate="2019-09-13" DateLastUpdated="2020-02-27" DateCreated="2020-02-27">
        <ClinVarSubmissionID localKey="c.1212_1217delTTATAA_HP:0000097" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001162289" DateUpdated="2020-02-27" DateCreated="2020-02-27" Type="SCV" Version="1" SubmitterName="NIHR Bioresource Rare Diseases, University of Cambridge" OrgID="505998" OrganizationCategory="consortium" OrgAbbreviation="NIHR BR RD" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">32581362</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">S005464</Attribute>
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">S011079</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APOL1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="22" alternateAllele="A" referenceAllele="AATAATT" start="36662041" stop="36662047" variantLength="7" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145343.2:c.1212_1217delTTATAA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="HP" ID="HP:0000097" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">32581362</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32581362</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>NIHR_Bioresource_Rare_Diseases_13k</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3659877" SubmissionDate="2021-09-13" DateLastUpdated="2021-09-19" DateCreated="2021-09-19">
        <ClinVarSubmissionID localKey="GDXSV:89377" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001859790" DateUpdated="2021-09-19" DateCreated="2021-09-19" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-02-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Benign</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APOL1" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:2816922</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003661.3:c.1160_1165del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_36_20210910111012</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4932470" SubmissionDate="2023-03-24" DateLastUpdated="2023-03-26" DateCreated="2022-05-24">
        <ClinVarSubmissionID localKey="NC_000022.11:g.36265996_36266001delATAATT|OMIM:612551" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002518488" DateUpdated="2023-03-26" DateCreated="2022-05-24" Type="SCV" Version="2" SubmitterName="Mendelics" OrgID="500035" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely risk allele</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Mendelics Assertion Criteria 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fxi2k7be/mendelics_assertion_criteria_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APOL1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000022.11:g.36265996_36266001delATAATT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="612551" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MENDELICS_CLINVAR_033</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4932470" TraitType="Disease" MappingType="XRef" MappingValue="612551" MappingRef="OMIM">
        <MedGen CUI="C2675525" Name="Focal segmental glomerulosclerosis 4, susceptibility to" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2924429" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2290365" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000097" MappingRef="HP">
        <MedGen CUI="C0017668" Name="Focal segmental glomerulosclerosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="26637" TraitType="Disease" MappingType="Name" MappingValue="FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4, SUSCEPTIBILITY TO" MappingRef="Preferred">
        <MedGen CUI="C2675525" Name="Focal segmental glomerulosclerosis 4, susceptibility to" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9856528" TraitType="Disease" MappingType="XRef" MappingValue="CN169374" MappingRef="MedGen">
        <MedGen CUI="CN169374" Name="not specified" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3659877" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="355013" TraitType="Disease" MappingType="Name" MappingValue="Hyalinosis, Segmental Glomerular" MappingRef="Preferred">
        <MedGen CUI="C0086432" Name="Hyalinosis, Segmental Glomerular" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1807723" TraitType="Disease" MappingType="XRef" MappingValue="612551" MappingRef="OMIM">
        <MedGen CUI="C2675525" Name="Focal segmental glomerulosclerosis 4, susceptibility to" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2290366" TraitType="Finding" MappingType="XRef" MappingValue="HP:0012593" MappingRef="HP">
        <MedGen CUI="C0445118" Name="Nephrotic range proteinuria" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

